Asaf Wyszynski, Ph.D. - Publications

Affiliations: 
Experimental and Molecular Medicine Dartmouth College, Hanover, NH, United States 
Area:
cancer, transcription factors

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Wyszynski A, Hong CC, Lam K, Michailidou K, Lytle C, Yao S, Zhang Y, Bolla MK, Wang Q, Dennis J, Hopper JL, Southey MC, Schmidt MK, Broeks A, Muir K, et al. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Human Molecular Genetics. PMID 27402876 DOI: 10.1093/hmg/ddw223  0.346
2015 Andrew AS, Gui J, Hu T, Wyszynski A, Marsit CJ, Kelsey KT, Schned AR, Tanyos SA, Pendleton EM, Ekstrom RM, Li Z, Zens MS, Borsuk M, Moore JH, Karagas MR. Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study. Bju International. 115: 238-47. PMID 24666523 DOI: 10.1111/Bju.12641  0.451
2014 Wyszynski A, Tanyos SA, Rees JR, Marsit CJ, Kelsey KT, Schned AR, Pendleton EM, Celaya MO, Zens MS, Karagas MR, Andrew AS. Body mass and smoking are modifiable risk factors for recurrent bladder cancer. Cancer. 120: 408-14. PMID 24122218 DOI: 10.1002/Cncr.28394  0.423
2011 Andrew AS, Gui J, Moore JH, Karagas MR, Pendleton E, Schned AR, Mason RA, Wyszynski A, Tanyos SA, Kelsey KT, Marsit CJ, Zens MS. Abstract A66: Apoptosis, cell cycle, DNA repair, immune, and metabolism pathway SNPs modify bladder cancer risk, recurrence, and survival Cancer Prevention Research. 4. DOI: 10.1158/1940-6207.Prev-11-A66  0.477
Show low-probability matches.